Zydus Lifesciences has received the EIR report from the USFDA for the inspection conducted at the injectables manufacturing facility at Zydus Biotech Park located at Changodar, Ahmedabad from June 5-13, 2023.
The inspection was a cGMP Inspection and had ended with NIL observations.